FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | |||
|
||||
Member
|
She looked great and sounded great she didn't talk about MS mostly about her aneurym she had and her rehab she went through and she said she hasn't been in a wheelchair for 6 months now and talked about the 2 movies she has coming out. I've always liked Teri Garr since Mr.Mom.
__________________
Diagnosed Probable MS 9/21/07 . Started Copaxone 10/16/07 3-6-9 the goose drank wine the monkey chewed tobacoo on the street car line the line broke the monkey got choked and they all went to heaven in a little row boat... . |
|||
![]() |
![]() |
"Thanks for this!" says: | AfterMyNap (06-18-2008), barb02 (06-17-2008), Desinie (06-17-2008), Girlie Girl (06-17-2008), Jappy (06-18-2008), jprinz99 (06-17-2008), Jules A (06-17-2008), karousel (06-17-2008), Keely (06-18-2008), McGimpy (06-17-2008), sugarboo (06-19-2008), Twinkletoes (06-19-2008), Victor H (06-17-2008), Vonn07 (06-17-2008) |
![]() |
#2 | |||
|
||||
Member
|
Hate to bring this subject up BUT I have some good information that MMP-9s which are elevated in active MS folks also cause aneurysms to GROW!!
The GOOD thing is that "things" that lower MMP-9s also slow aneurysm growth. I am posting about these MMP critters in an Avonex thread. jackD 1: Neurology. 1999 Oct 22;53(7):1397-401. Links Comment in: Neurology. 1999 Oct 22;53(7):1380-1. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis.Waubant E, Goodkin DE, Gee L, Bacchetti P, Sloan R, Stewart T, Andersson PB, Stabler G, Miller K. UCSF/Mt. Zion Multiple Sclerosis Center, San Francisco, CA 94115, USA. OBJECTIVE: To 1) compare monthly serum levels of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of MMP-type 1 (TIMP-1) in patients with relapsing-remitting MS (RRMS) versus healthy controls and 2) determine the relationship among monthly serum levels of MMP-9 and TIMP-1 and MRI activity. BACKGROUND: Activated T-cells and macrophages secrete MMPs that may facilitate their migration across vascular subendothelial basement membranes into the CNS. The serum concentration of MMP-9 is reported to be higher in patients with RRMS than healthy controls. METHODS: Monthly evaluations including gadolinium-enhanced (Gd+) brain MRI and measures of serum MMP-9 and TIMP-1 were performed for up to 15 months in 24 patients with RRMS and for up to 4 months in 10 controls. RESULTS: Serum MMP-9 but not TIMP-1 levels are elevated in RRMS patients compared to healthy controls (p = 0.025, p = 0.61). In a univariate analysis, high MMP-9 and low TIMP-1 levels precede appearance of new Gd+ lesions (respectively; odds ratio = 3.3, p = 0.008; odds ratio = 2.2, p = 0.086). In a multivariate analysis, in comparison to months when MMP-9 is low and TIMP-1 high, MRI scans obtained the month following high MMP-9 and low TIMP-1 serum concentrations are more likely to report new Gd+ lesions (p = 0.0006, odds ratio = 21.5). CONCLUSION: An increase in the activity of matrix metalloproteinase-9 (MMP-9) relative to tissue inhibitor of MMP-type 1 (TIMP-1) may be related to formation of new MS lesions, suggesting that serum levels of MMP-9 and TIMP-1 may be surrogate markers of disease activity in relapsing-remitting MS. PMID: 10534241 [PubMed - indexed for MEDLINE] 1: Stroke. 2007 Jan;38(1):162-9. Epub 2006 Nov 22. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N. Kyoto University, Graduate School of Medicine, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, Japan. BACKGROUND AND PURPOSE: Mechanisms of initiation, progression and rupture of cerebral aneurysms have not yet been fully understood despite its clinical significance. Matrix metalloproteinases (MMPs) are a family of proteinases which are involved in the remodeling of vascular walls. In the present study, we investigated the significance of MMPs in the progression of cerebral aneurysms. METHODS: Cerebral aneurysms were experimentally induced in 7-week-old male Sprague-Dawley rats. MMP-2 and MMP-9 expression was examined by immunohistochemistry and RT-PCR. Gelatinase activity in aneurysmal walls was assessed by in situ zymography. A selective inhibitor for MMP-2, -9 and -12, tolylsam, was used to examine the effect of inhibition of MMP-2 and MMP-9. RESULTS: Macrophages infiltrated in arterial walls of experimentally induced rat cerebral aneurysms and expressed MMP-2 and -9. Macrophage infiltration and MMP expression was increased with the progression of aneurysms. Gelatinase activity attributable to MMP-2 and MMP-9 increased in arterial walls of rat cerebral aneurysms. Furthermore, tolylsam reduced the ratio of advanced aneurysms in our rat model. CONCLUSIONS: These data suggest that macrophage-derived MMP-2 and -9 may play an important role in the progression of cerebral aneurysms. The findings of this study will shed a new light into the pathogenesis of cerebral aneurysms and highlight the importance of inflammatory response causing the degeneration of extracellular matrix in the process of this disease. PMID: 17122420 [PubMed - indexed for MEDLINE] Last edited by jackD; 06-18-2008 at 10:23 PM. |
|||
![]() |
![]() |
Reply |
|
|
![]() |
||||
Thread | Forum | |||
Watch Angela Lansbury on Today show for ALS. | ALS News & Research | |||
Meda Alert: Angela Lansbury on Today Show | ALS News & Research | |||
Al Roker Jokes about Epilepsy on the TODAY show | Epilepsy | |||
Teri Garr recovering from surgery | Multiple Sclerosis | |||
today show, matt lauer and MJF ad | Parkinson's Disease |